Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Top Cited Papers
- 1 April 2008
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 31 (4), 345-351
- https://doi.org/10.1016/j.ijantimicag.2007.12.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal FunctionAntimicrobial Agents and Chemotherapy, 2003
- Pharmacodynamic Interactions of Antibiotics Alone and in CombinationClinical Infectious Diseases, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- The Economic Potential of Dual Individualisation MethodologiesPharmacoEconomics, 1996
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Cefepime Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Safety, Tolerance, and Pharmacokinetics of Cefepime Administered Intramuscularly to Healthy SubjectsThe Journal of Clinical Pharmacology, 1990
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976